Department of Neurosurgery, Southwest Hospital, Chongqing, China.
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
EMBO J. 2019 Oct 1;38(19):e96659. doi: 10.15252/embj.201796659. Epub 2019 Aug 27.
Loss of the histone H3.3-specific chaperone component ATRX or its partner DAXX frequently occurs in human cancers that employ alternative lengthening of telomeres (ALT) for chromosomal end protection, yet the underlying mechanism remains unclear. Here, we report that ATRX/DAXX does not serve as an immediate repressive switch for ALT. Instead, ATRX or DAXX depletion gradually induces telomere DNA replication dysfunction that activates not only homology-directed DNA repair responses but also cell cycle checkpoint control. Mechanistically, we demonstrate that this process is contingent on ATRX/DAXX histone chaperone function, independently of telomere length. Combined ATAC-seq and telomere chromatin immunoprecipitation studies reveal that ATRX loss provokes progressive telomere decondensation that culminates in the inception of persistent telomere replication dysfunction. We further show that endogenous telomerase activity cannot overcome telomere dysfunction induced by ATRX loss, leaving telomere repair-based ALT as the only viable mechanism for telomere maintenance during immortalization. Together, these findings implicate ALT activation as an adaptive response to ATRX/DAXX loss-induced telomere replication dysfunction.
组蛋白 H3.3 特异性伴侣成分 ATRX 或其伴侣蛋白 DAXX 的缺失经常发生在采用端粒延长的替代机制(ALT)进行染色体末端保护的人类癌症中,但潜在的机制仍不清楚。在这里,我们报告称,ATRX/DAXX 不作为 ALT 的直接抑制开关。相反,ATRX 或 DAXX 的耗竭逐渐诱导端粒 DNA 复制功能障碍,不仅激活同源重组修复反应,还激活细胞周期检查点控制。从机制上讲,我们证明这个过程依赖于 ATRX/DAXX 组蛋白伴侣功能,而与端粒长度无关。结合 ATAC-seq 和端粒染色质免疫沉淀研究表明,ATRX 的缺失会引发端粒逐渐去凝聚,最终导致持续的端粒复制功能障碍的出现。我们进一步表明,内源性端粒酶活性不能克服 ATRX 缺失诱导的端粒功能障碍,使得基于端粒修复的 ALT 成为永生过程中端粒维持的唯一可行机制。总之,这些发现表明 ALT 的激活是对 ATRX/DAXX 缺失诱导的端粒复制功能障碍的适应性反应。